The glucocorticoid receptor (GR) has a critical role in determining the brain's capacity to respond to stress, and has been implicated in the pathogenesis of psychiatric illness. We hypothesized that key changes in cortical GR occur during adolescence and young adulthood, at a time when individuals are at increased risk of developing schizophrenia, bipolar disorder and major depression. We investigated the mRNA and protein expression of GR in the dorsolateral prefrontal cortex across seven developmental time points from infancy to adulthood. GR mRNA expression, determined by microarray and quantitative real-time PCR, was lowest in neonates and peaked around young adulthood. Western blotting revealed two dynamic patterns of GRa protein expression across the lifespan, with N-terminal variants displaying differing unique patterns of abundance. GRa-A and a 67-kDa GRa isoform mirrored mRNA trends and peaked in toddlers and late in adolescence, whereas a 40-kDa isoform, very likely a GRa-D variant, peaked in neonates and decreased across the lifespan. GRa protein was localized to pyramidal neurons throughout life and most strikingly in young adulthood, but to white matter astrocytes only in neonates and infants ( < 130 days). These results suggest that the neonatal and late adolescent periods represent critical windows of stress pathway development, and highlight the importance of white matter astrocytes and pyramidal neurons, respectively, at these stages of cortical development. Evidence of dynamic patterns of GR isoform expression and cellular localization across development strengthens the hypothesis that windows of vulnerability to stress exist across human cortical development.
Introduction
The ability to respond to stress is critical to normal human development and good psychiatric health. In circumstances of physical and psychosocial stress, the hypothalamic-adrenal-pituitary (HPA) axis releases cortisol (CORT), which binds the glucocorticoid receptor (GR) and mediates the conversion of lipids and proteins to glucose, modulates cell proliferation and survival, alters immune function and controls inflammation, all in a tissue-specific manner. 1 In the brain, GR has a role in the negative feedback regulation of stress response 2 and modulates the transcription of genes required to equip the brain to respond to stress itself. 3 The complex actions of glucocorticoids (GCs) in specific tissues, 4 with age 5 and in disorders of GC resistance, 6 may be explained by the significant diversity of GR transcripts and isoforms ( Figure 1 ). This diversity includes 13 exon 1 mRNA variants 7, 8 and 8 N-terminal variants, which arise from the predominant GR isoform, GRa, and differ in size from 94 to 54 kDa based on the location of their translation start site in exon 2 9 ( Figure 1 ). Other GR protein isoforms have been described, including GRb, GR-A, GR-P, GRg and GRD313-338. [10] [11] [12] [13] GRa primarily resides in the cytosol and translocates to the nucleus on ligand binding to initiate changes in gene transcription. 14 In contrast, the GRb and GRa-D 1À3 isoforms are present only in the nucleus 15 and may be involved in determining tissue-specific GC sensitivity. 6, 11, 16 GR has a critical role in normal human brain development 17 and controls the transcription of a range of genes critical to psychiatric health. Brainderived neurotrophic factor, for example, has been shown to be downregulated by GR [18] [19] [20] as well as in schizophrenia. 21 Parvalbumin, a calcium-binding protein used as a marker of interneuron development, is upregulated by GR 22 and altered in schizophrenia. 23, 24 The involvement of GR in modulating neurotransmitter availability through downregulation of monoamine oxidase A, which catabolizes dopamine, serotonin and noradrenaline and has been implicated in psychiatric illness, 25, 26 has also been suggested. 22 Finally, GR downregulates the expression of GAP-43, 27 a mediator of synaptic plasticity, which is decreased in schizophrenia and bipolar disorder, 28, 29 altered by maternal deprivation 30 and upregulated by antidepressants. 31 GR abnormalities and dysfunction of the HPA axis have been implicated in mental illness. Prenatal insults and stressful early life events have been shown to affect human GR expression and HPA axis function through epigenetic mechanisms, 32, 33 and may contribute to risk for psychiatric illness. 34 In individuals with schizophrenia and major depression, abnormal CORT responsivity has been observed during the dexamethasone suppression test, [35] [36] [37] and abnormally high levels of CORT have been observed at certain times of the day. [38] [39] [40] [41] Decreased GR mRNA expression in schizophrenia, bipolar disorder and major depression has been shown in a range of cortical brain regions including the dorsolateral prefrontal cortex (DLPFC). [42] [43] [44] A number of singlenucleotide polymorphisms in the GR gene have been shown not only to affect HPA axis reactivity 45, 46 but also been associated with major depression. 47 The prefrontal cortex has been implicated widely in psychiatric illness, 23 and through GR it can mediate the negative feedback regulation of the HPA axis. 48 To explore and clarify the link between altered stress responsivity and the pathogenesis of neurodevelopmental disorders, 49 an understanding of the normal cortical development of GR is critical.
Across the human lifespan, adaptive changes in stress response pathways take place to keep pace with changing environmental and physiological demands. Basal levels of salivary and plasma CORT decrease immediately after birth, 50 and then increase with advancing age among both men and women from 9 to 83 years, [51] [52] [53] mirroring changes observed in rodents. 2 HPA axis stress reactivity changes dynamically over human development, decreasing in the immediate postnatal period in neonates 54 and increasing as individuals approach adolescence. 53 In adults, metaanalyses have suggested both increasing and decreasing stress responsivity with ageing. 55, 56 Within the human brain, GR mRNA has been shown to be present in the vast majority of pyramidal neurons, B50% of the non-pyramidal neurons and 10% of the glia in the hippocampus and prefrontal, temporal and entorhinal cortices. 43, 57 Across rodent development, consistent increases in hippocampal and cortical GR mRNA 58, 59 and cortical, limbic and subcortical GR protein 2 have been shown. Furthermore, changes in abundance of multiple GR protein isoforms across rodent hippocampal development have been described. 60 In our previous study of human GR mRNA expression, dynamic regulation was seen in the cortex, but not in the hippocampus, with higher expression being observed in grey matter layers II-VI of the DLPFC in adolescent and adult groups than in infant or aged groups. 61 The generalizability and significance of these findings are limited because initial observations have not been replicated, did not include toddler and school-age individuals, and did not extend to the study of the abundance and localization of GR protein. Therefore, we set out to replicate and extend our findings, to clarify how GR is developmentally regulated in the human DLPFC.
Materials and methods

Tissue collection
Frozen tissue from the middle frontal gyrus of 66 normal control cases from 6 weeks to 49 years of age Table 1 ). For immunohistochemistry, 14-mm thick coronal sections of the middle frontal gyrus from 14 representative cases of the 66 cases described above were used. Tissues from the middle frontal gyrus of the two additional infants (aged 4 and 9 months) and adults (aged 69 and 77 years) were combined for use as internal controls in western blotting analyses.
Microarray and qPCR analyses RNA isolation, RNA quality assessment, microarray and qPCR analyses were conducted as previously described. 62 Total RNA was extracted from developmental cohort tissues for microarray (n = 45) and qPCR analyses (n = 57) using Trizol (Invitrogen, Carlsbad, CA, USA), and the quality of extracted total RNA determined using the Agilent Bioanalyzer 2100 (Agilent Technologies, Palo Alto, CA, USA). Six samples were excluded with RNA integrity number < 5.2. cDNA was synthesized in three reactions using the Superscript First-Strand Synthesis Kit (Invitrogen). For microarray analysis, total RNA was purified through Qiagen RNA miniKit columns (Qiagen, Valencia, CA, USA), prepared according to the Affymetrix protocol and hybridized to HG-U133 version 2.0 þ (GeneChips, Affymetrix, Santa Clara, CA, USA). Affymetrix Microarray Suite (MAS 5.0) was used for image processing. For qPCR analysis, a TaqMan Gene Expression Assay (Applied Biosystems, Foster City, CA, USA) for pan GR (Hs00230818_m1) was used. Four 'housekeeper' genes that did not change expression with development were chosen: hydroxymethylbilane synthase (Hs00609297_m1), glucuronidase-b (Hs99999908_m1), ubiquitin C (Hs00824723_m1) and cyclophilin A (Hs99999904_m1). 63 Serial dilutions of pooled cDNA (from seven samples, one from each developmental time point) were included on every qPCR plate for quantification of sample expression by the relative standard curve method. Efficiencies of the qPCR reactions ranged from 77-100%, with R 2 values ranging between 0.95 and 1.00. One sample was excluded because the standard deviation of its triplicates was greater than 30% of the mean. Two outliers were excluded from qPCR analysis because their normalized expression values were greater than 2 s.d. from the group mean. For details, see Supplementary Methods.
Anti-GRa antibodies
An anti-GRa antibody targeting amino acids 727-777 of the GRa C terminus (P-20; sc-1002; Santa Cruz, Ca, USA) was used from two product batches. P-20 batch 1 antibody was used for GRa protein quantification by western blotting, pre-absorption and 3,3 0 -diaminobenzidine (DAB) immunohistochemistry. Fluorescent immunohistochemistry and grey/white matter western blot comparisons were conducted with P-20 batch 2. An additional anti-GRa antibody to the same region of the GRa C terminus (PA1-516, Affinity Bioreagents, Golden, CO, USA) was used for comparative purposes.
Western blotting
Frozen tissues (n = 57, Supplementary Table 1) were homogenized by grinding with a pestle in buffer (0.05 M Tris pH 7.5, 50% glycerol, 2 mM AEBSF, 0.015 mM aprotinin, 0.038 mM leupeptin, 0.030 mM pepstatin A, 0.028 mM E-64, 0.08 mM bestatin; Sigma, St Louis, MO, USA) and diluted to 2 mg ml À1 after protein concentration determination by Bradford assay (Sigma). A volume of 7.5 mg of crude protein homogenate was heated (2 min, 95 1C), loaded alongside a molecular weight ladder (Precision Plus, BioRad, Hercules, Ca, USA) onto 10% bis-tris polyacrylamide gels (Bio-Rad) and electrophoresed for 45 min at 200 V. Proteins were transferred onto nitrocellulose membranes (Bio-Rad) at 100 V for 2 h, which were then blocked for 2 h at 4 1C in phosphate-buffered saline (PBS) containing 0.1% Tween-20 and 5% skim milk and incubated overnight at 4 1C in primary rabbit anti-GRa antibody (batch 1, 1:200 dilution in 5% skim milk), mouse anti-b-actin (1:10 000; MAB1501, Millipore, Billerica, MA, USA) or mouse anti-V5 (1:5000; cat. no. 46-0705, Invitrogen). The following day, blots were incubated in goat anti-rabbit (1:2000; Millipore) or goat anti-mouse (1:5000; Millipore) IgG peroxidaseconjugated secondary antibody for 1 h at room temperature (RT). Immunoreactive bands were detected using the ECL Western Blotting detection kit (Amersham Biosciences, Piscataway, NJ, USA) or enhanced chemiluminescent reagent (Millipore), visualized on the Chemidoc XRS Molecular Imager system (Bio-Rad) and analysed using Quantity One 1-D software (Bio-Rad). For details of western blotting of pre-absorption and grey/white matter comparisons, see Supplementary Methods.
Immunohistochemistry DAB immunohistochemistry was performed as previously described. 64 Fresh frozen tissue sections were thawed (RT, 20 min) and fixed in 4% paraformaldehyde in PBS (137 mM NaCl, 2.7 mM KCl, 8 mM Na 2 HPO 4 , 2 mM KH 2 PO 4 , pH 7.4) for 10 min at 4 1C. Slides were treated with 75% MeOH þ 0.75% H 2 O 2 solution (RT, 20 min) and incubated with 10% normal goat serum in diluent (0.05% bovine serum albumin, 0.3% Triton X-100 in PBS) for 1 h at RT. Anti-GRa primary antibody (batch 1, 1:200) was applied to the sections overnight at 4 1C, followed by goat anti-rabbit IgG biotinylated secondary antibody (1:500, Vector Laboratories, Burlingame, Ca, USA) for 1 h at RT. Slides were then incubated at RT in an avidin-biotin-peroxidase complex (Vectastain ABC kit; Vector Laboratories) for 1 h, treated with DAB (Sigma; 12 mM in PBS with 0.003% H 2 O 2 ) for 5-7 min, stained with Nissl (1.5 min exposure to 0.02% thionin) and coverslipped. Double-label fluorescent immunohistochemistry was conducted with the following alterations to the protocol described above. Slides were not treated with 75% MeOH þ 0.75% H 2 O 2 solution and were blocked with 10% donkey serum (30 min). Slides were incubated with anti-GRa primary antibody (batch 2, 1:200) at 4 1C overnight and with donkey anti-rabbit secondary antibody (1:500, Millipore) at RT for 1 h before reblocking in serum (30 min) and incubation with anti-glial fibrillary acidic protein primary antibody (1:2000, Millipore) or anti-neuronal nuclei (NeuN) primary antibody (1:1000, Millipore) at 4 1C overnight and donkey anti-mouse secondary antibody (1: 500, Millipore) at RT for 1 h. Slides were then washed and treated with 4,6-diamidino-2-phenylindole (1:1000) in PBS for 5 min, and finally with 5 mM CuSO 4 in 50 mM CH 3 COONH 4 (pH 5.0) for 20 min for the removal of autofluorescence 65 before coverslipping.
Cloning
Plasmids were constructed containing DNA fragments encoding GRa N-terminal variants GRa-A, GRa-C 1 and GRa-D 1 with V5 tags using the following primers: GRa-A (fwd) ATGGACTCCAAAGAATCATTAAC, GRa-C 1 (fwd) ATGGGACTGTATATGGGAGAG, GRa-D 1 (fwd) ATGTC TGCCATTTCTGTTCATG, common reverse CTTTTGAT GAAACAGAAGTTTTTTG. cDNAs of these fragments were ligated into pcDNA3.1-V5-His using the TOPO TA cloning kit (Invitrogen) according to the manufacturer's instructions. Clones were screened for the direction of insert ligation using BamHI þ ScaI (GRa-A and GRa-C 1 ) and HindIII (GRa-D 1 ), and verified by sequencing. HeLa and HEK293 cell lines were obtained from the American Type Culture Collection (Manassas, VA, USA) and grown at 37 1C in a 5% CO 2 atmosphere. HEK293 and HeLa cells were cultured in Dulbecco's modified Eagle's medium and RPMI, respectively, both containing 10% (v/v) fetal bovine serum supplemented with glutamax (2 mM). On day 1, cells were seeded in uncoated (HeLa) and poly-L-lysine-coated (HEK293) 35 mm dishes at a density of 1 Â 10 6 cells per dish. On day 2, the cells were transfected for 24 h with pcDNA3.1-V5-His-GRa-A, pcDNA3.1-V5-His-GRa-C 1 or pcDNA3.1-V5-His-GRa-D 1 using Lipofectamine LTX transfection reagent (Invitrogen). On day 3, the cells were washed twice in PBS and then lysed. Preparations of HeLa and HEK293 cells transfected with GRa-A, GRa-C 1 and GRa-D 1 were lysed with RIPA buffer containing protease inhibitors (Sigma) at 4 1C for 10 min, centrifuged at 12 000 g for 2 min and the pellet discarded. Parallel preparations were also lysed in tissue homogenization buffer, after scraping into 1 ml of ice-cold PBS. Protein concentrations of RIPA cell lysates were determined by BCA assay (Thermo Scientific, Waltham, MA, USA) and tissue homogenization buffer lysates by Bradford assay.
Statistical analysis
Normalization and analysis of microarray data were performed using R and Bioconductor software (open source software, www.bioconductor.org), with which differential gene expression across chronological age was analysed in a linear regression model. All qPCR reactions were performed in triplicate and the results analysed using Statistica 7 (StatSoft, Tulsa, OK, USA). Expression levels were normalized to the geometric mean of four 'housekeeper' genes. Analysis of covariance was used to assess the significance of changing GRa expression, with normalized expression, group and pH as the dependent, grouping and continuous variables, respectively. Fisher LSD post hoc analysis was used to identify significant differences between groups. For western blotting of the developmental cohort, samples were run in duplicate in separate experimental runs. The optical density of each immunoreactive (IR) band was normalized to the b-actin IR band detected in the same lane and an internal control loaded onto the same gel. Results were presented as the geometric mean of normalized optical densities from both runs, expressed as a percentage of adult levels (100%), and analysed using one-way analysis of variances and Fisher LSD post hoc analysis.
Results
GR mRNA expression in the developing DLPFC
Microarray analysis revealed a gradual and significant increase in GR mRNA expression across the human lifespan (r = 0. 88, P < 1 Â 10 À14 , Figure 2a ) in all three GRa probe sets, with an approximate increase of 225% from the neonate to young adult groups. There was a slight (B7%) nonsignificant decrease from young adult to adult groups, suggesting a levelling off of GR mRNA levels in adulthood.
A significant change in pan GR mRNA expression across development was also detected by qPCR (analysis of covariance, F = 6.51, df = 6,51, P < 1 Â 10 -4 ; Figure 2b ), covarying with pH. The lowest expression of GRa mRNA was observed in neonates and the highest in teenagers (a 125% increase, P < 1 Â 10 -5 ). A significant decrease was observed in adults relative to teenagers (a 28% decrease, P < 0.01).
GR protein expression in the developing DLPFC Changes in GRa protein expression across the human lifespan were identified by western blotting. Initial observations suggested some variation in GRa detection between anti-GRa antibody batches, and therefore western blots using P-20 batch 1 and batch 2 antibodies were compared using a representative set of developmental DLPFC tissue samples (Figures 2c  and d) . Five IR bands of approximately 105, 67, 50, 40 and 25 kDa were identified using both batches of antibody. The pattern of intensities for each band between samples was consistent for both batches of antibody. However, the P-20 batch 1 antibody displayed substantially greater affinity for band 4 than did P-20 batch 2. Comparisons using the same samples probed with a distinct anti-GRa antibody (PA1-516) identified a strong IR band 2 and weak IR band 3 (data not shown). Specificity of the P-20 GRa To determine whether the five GRa IR bands observed in human DLPFC tissue would be consistent with GRa isoforms generated by alternate start codon usage, three N-terminal GRa variants were cloned, transfected into HeLa and HEK293 cells and analysed alongside DLPFC tissue samples in western blots with V5 antibody detection. IR bands of the GRa-A (98 kDa), GRa-C 1 (88 kDa) and GRa-D 1 (60 kDa) cloned ). Optical densities are the geometric mean of duplicate runs, displayed as a percentage of the mean of the adult group. *P < 0.05, **P < 0.005. Error bars represent s.e.m. (h) Intensity of IR band 4 decreases across human cortical development (IR band 4, ANOVA F = 3.03, df = 6, 51, P < 0.05). *P < 0.05, **P < 0.005.
Dynamic changes in GR across human cortical development
D Sinclair et al products were evident in anti-V5 antibody probed blots (Figure 2e ), although the GRa-D 1 variant band ran around 50 kDa, 10 kDa smaller than anticipated. Each GR clone also generated a number of smaller V5-tagged GR variants. In addition to the GRa-A, GRa-C 1 and GRa-D 1 N-terminal variants, smaller variants of 65, 45, 35 and 30 kDa were identified. GRa-A gave rise to GRa-C 1, GRa-D 1 and some additional variants, as would be expected from the use of alternative translation start sites that would be present in the longer clone (Figure 1 ). The same results were observed for transfections of HEK293 cells, and for both cell lines lysed with tissue homogenizing buffer (data not shown). When the western blot described above was probed with an anti-GRa antibody (Figure 2f ), the V5 IR bands evident in Figure 2e were seen to be stained by the anti-GRa antibody. Quantification of GRa expression in the entire developmental cohort was undertaken with the P-20 batch 1 antibody. Staining of GRa IR band 3 was not consistent between duplicate runs, and therefore bands 1, 2, 4 and 5 were quantified. The normalized intensities of all IR bands did not correlate with RNA integrity number, pH or post-mortem interval.
IR band 1 (GRa-A), band 2 (67 kDa GRa) and band 4 (GRa-Dx) changed significantly across the lifespan (Figure 2g ). IR band 1 (analysis of variance F = 2.67, df = 6, 51, P < 0.05) and band 2 (analysis of variance F = 10.48, df = 6, 50, P < 1 Â 10 -6 ) displayed patterns of increasing abundance from neonates to toddlers, remained stable up to adolescence, and decreased into adulthood. This trend broadly mirrored the pattern of GRa mRNA expression across development. The intensity of IR band 1 (GRa-A) was significantly increased, relative to neonates, in toddlers (a 147% increase from neonates, P < 0.05) and teenagers (a 167% increase from neonates, P < 0.01). It was then significantly decreased in young adults (a 58% decrease from teenagers, P < 0.05) and trended in adults (a 17% decrease from teenagers, P = 0.09). IR band 2 (67 kDa GRa) was the predominant band and was significantly increased in toddlers (a 300% increase from neonates, P < 1 Â 10 -5 ), school-age individuals (a 242% increase from neonates, P < 1 Â 10 -4 ) and teenagers (a 288% increase from neonates, P < 1 Â 10 -5 ). It did not differ significantly between toddlers, school age or teenage cases, but was significantly decreased in young adults (a 45% decrease from teenagers, P < 0.001) and nonsignificantly in adults (a 21% decrease from teenagers, P = 0.09).
IR band 4 (40-kDa GRa, GRa-Dx) also showed a significant change across development (analysis of variance F = 3.03, df = 6, 51, P < 0.05; Figure 2h ), but in contrast to IR bands 1 and 2 was most abundant in neonates and decreased throughout life to be least abundant in young adulthood. Relative to neonates, IR band 4 was significantly decreased in toddlers, teenagers and adults (a 25-30% decrease, P < 0.05) and school age and young adult cases (a 35-40% decrease, P < 0.005).
Cellular localization of GRa protein in the DLPFC across the lifespan Immunohistochemistry revealed changes in the cellular localization of GRa protein in the DLPFC. Early in life, in all cases younger than 130 days (n = 4), moderate GRa immunoreactivity was observed in the nuclei and immediately adjacent soma of pyramidal neurons (Figure 3b ), which were shown to coexpress the neuronal marker NeuN (Figures 4a-d) . Abundant GRa was also detected at the pial surface and in white matter cells with radiating processes typical of astrocytes (Figures 3a and c) . GRa-positive white matter cells were confirmed to coexpress glial fibrillary acidic protein, an astrocyte marker (Figures 4e-h ). The remaining infants and all toddlers (130 days-4 years, n = 4) also displayed immunostaining at the pial surface and in the nuclei and soma of pyramidal neurons (Figures 3d and e) ; however, little GRa protein was seen in white matter astrocytes (Figure 3f ). In all teenage and young adult (15-25 years, n = 6) cases, GRa immunoreactivity was observed at the pial surface, as well as intense staining in the soma and extending into the apical dendrites of NeuN coexpressing pyramidal neurons (Figures 3g and h; Figures 4i-l) . Strong GRa immunostaining of neuronal nuclei was only observed by DAB immunohistochemistry with the P-20 batch 1 antibody (Figure 3h ). By fluorescent immunohistochemistry with the P-20 batch 2 antibody, substantially less GRa immunoreactivity of nuclei was observed (Figures 4i-l) . No appreciable GRa immunostaining was seen in white matter astrocytes in cases older than 130 days (Figures 3i; Figures 4m-p) . Some autofluorescence was observed in fluorescent immunohistochemistry of adult white matter samples (Figure 4m arrows). Confirming immunohistochemical findings, increased GRa protein expression in neonatal white matter relative to adult matter was shown by direct comparison of GRa protein from grey and white matter (see Supplementary Results).
Discussion
The results of this study indicate that a significant level of control over GR is exercised across human cortical development. At a transcriptional level, GR mRNA expression was shown to increase across development until the teenage/young adult years, Dynamic changes in GR across human cortical development D Sinclair et al confirming earlier findings with a restricted cohort (consisting of infant, adolescent, young adult, adult and aged samples) using in situ hybridization. 61 Our current study shows that the peak in GRa mRNA expression in adolescence is a result of the gradual increase in GRa expression throughout pre-adolescent life. The concurrent pre-adolescent increase in GR mRNA with plasma CORT suggests that, as with rodents, 2 hormone-induced downregulation of GR does not occur before young adulthood, but instead both ligand and receptor are coordinately increased as the human frontal cortex develops.
Characterization of GRa isoforms present in the human DLPFC tissue by comparison with cloned, V5-tagged N-terminal GRa variants confirmed that multiple true GRa variants are likely to exist in vivo in addition to the archetypal full-length 94 kDa receptor. Tissue IR bands 1-5 corresponded to cloned GRa N-terminal variants within a margin of B10 kDa, with tissue and clone bands affected by possible posttranslational modification and the presence of the V5 tag. The predominant isoform in brain tissue appeared to be the 67 kDa isoform, the most consistently intense band regardless of the anti-GRa antibody used. This isoform represents a novel isoform with an intact C terminus, which arises potentially because of the use of an alternative translation start site or by exon skipping. Many earlier studies have described a range of unidentified bands in this size range in a number of human cell lines and non-brain rodent tissues. 9, 66, 67 If the 67-kDa isoform arises from an uncharacterized translation start site, this variant may be missing a component of the AF1 transactivation domain, potentially affecting its ability to activate target gene transcription. Alternatively, of the other characterized GRa isoforms (including GR-A, GRb, Dynamic changes in GR across human cortical development D Sinclair et al GR-P, GRg and GRD313-338), only GR-A is truncated but retains exon 9a, which contains the epitope targeted by the anti-GRa antibody in this study. This GR-A isoform arises from an in-frame deletion of exons 5-7, the product of which is in an B71 kDa protein missing the nuclear localization signal and AF2 transactivation domain (Figure 1 ). 10 The functional characteristics of this isoform have not been described, although it was initially identified in a GCresistant human multiple myeloma cell line. 10 Given its abundance in the DLPFC, the 67-kDa GRa isoform could have a critical role in the stress signalling of the human brain in health and psychiatric illness; however, its identity and functional properties remain to be determined.
GRa-A (GRa IR band 1) displayed a pattern of expression in the DLPFC, which mirrored GR mRNA changes and increased threefold to a peak in late adolescence. GRa-A is the full-length GRa receptor, which is capable of inducing luciferase expression at GC response elements in a dexamethasone dosedependent manner. 9 Given that the transcriptional response of cells in response to GCs is correlated with their GR expression, 68 the increased abundance of this receptor isoform late in adolescence is likely to amplify the GC-induced activation and repression of target genes in response to stress at this time of life. During adolescence, humans encounter what are arguably some of the most stressful experiences of life, as the transition to independence and maturity introduces a plethora of social, environmental and physical challenges. Increased GR expression in the frontal cortex during adolescence may equip individuals to be more responsive to situations of acute Dynamic changes in GR across human cortical development D Sinclair et al stress at this time. In addition, however, individuals in late adolescence could be most susceptible to overstimulation of stress pathways through GR, resulting in a heightened sensitivity to the deleterious effects of intense or enduring stress. The robustly expressed, yet novel, 67-kDa GRa variant (IR band 2) was seen to increase fourfold throughout human cortical development to a peak, in toddler and teenage groups, in the same developmental pattern as GRa-A. Given that it is the most abundant isoform identified in the DLPFC samples in this study, the determination of the functional properties of this 67-kDa variant is critical to an understanding of the relevance of the peak in its expression in toddlers and later in adolescence.
The discovery of the 40-kDa GRa-Dx variant, potentially GRa-D 2 or GRa-D 3 , which is expressed most strongly at the start of life before decreasing to a plateau after toddlerhood, suggests an additional role for GR in development. GRa-D variants lack the entire AF1 transactivation domain, have limited capacity to induce transcription at GC response elements in response to dexamethasone, and remain in the nucleus regardless of the presence of a ligand. 9 Each N-terminal isoform activates and represses the expression of a range of unique genes, with GRa-D 3 being the most selective. 9 The increased expression of a GRa-D variant during the neonatal period may therefore have significant functional consequences, fulfilling a role in early post-natal brain development, which contrasts the role of the increasingly abundant GRa-A and 67-kDa GRa variants in this early life stage.
The patterns of GR-a isoform expression observed in this study may be relevant to the emergence of a 'stress hyporesponsive period' early in life. This period has been proposed in humans on the basis of evidence in rodents which reveals that, early in postnatal life, the HPA axis response to mild stressors is dampened without affecting responses to acute stressors. 69, 70 It is possible that the increased expression immediately postnatally of a less transcriptionally capable GR isoform (such as GRa-D 2 or GRa-D 3 ) may alter the responsivity of the brain to circulating GCs and contribute to changes in the HPA axis during the stress hyporesponsive period.
The anatomical differences across development in GRa protein expression within the DLPFC also highlighted the importance of the neonatal and late adolescent periods. All cases younger than 130 days displayed strong GRa immunoreactivity in glial fibrillary acidic protein-positive white matter astrocytes, indicating a possible role for these cells in particular in the neonatal stress response. It has been proposed that elevation of GCs may be partially responsible for glial cell abnormalities in major depressive disorder, bipolar disorder and schizophrenia, 71 particularly as these changes can occur in the white matter. 72 The increased expression of GRa in neonatal astrocytes may suggest that the neonatal developmental period represents a window of vulnerability of these cells to the deleterious effects of elevated GCs. As the frontal cortex matures, GRa expression increases in pyramidal neurons, as these cells become the major target for GCs. Nuclear localization of GRa immunoreactivity in pyramidal neurons was observed most strongly by DAB immunohistochemistry using the P-20 batch 1 antibody, which has an increased affinity for GRa IR band 4 (the GRa-Dx variant). The GRa-D 1À3 variants have been shown to remain in the nucleus regardless of the presence of a ligand. 9 Therefore, more prominent nuclear GRa immunoreactivity may have resulted from increased detection of the GRa-Dx variant by the P-20 batch 1 antibody.
The observed patterns of GRa isoform expression and cellular localization across the human lifespan support the hypothesis that the neonatal and late adolescent periods may represent critical windows in the development of the stress response in the prefrontal cortex 73 ( Figure 5 ). Windows of vulnerability in development have previously been proposed on the basis of patterns of evidence from normal development (such as timing of synapse formation and pruning) and psychiatric illness (including age of onset for schizophrenia, bipolar disorder and major depression). 74, 75 Evidence of distinctive molecular characteristics in the brain's stress response mechanisms at different stages of development strengthens the proposal that an individual's stress responses may differ at these stages, increasing or decreasing their vulnerability to stressful environmental insults. An understanding of Figure 5 A proposed model of the development of stress response pathways in the human prefrontal cortex, containing windows of heightened sensitivity (arrows) to environmental insult based on trends in the neuroanatomical distribution of GRa-positive cells (pink) and the temporal expression of GRa mRNA (bars) and GRa protein variants (GRa-Dx, blue; GRa-A and 67-kDa GRa, green). The trend in plasma CORT levels across the lifespan (orange) is also shown, with data drawn from Sippell et al. 50 and Van Cauter et al.
windows of stress vulnerability may enable targeted intervention to buffer stress in susceptible individuals at these times of life, softening the impact of such stress and potentially decreasing the likelihood of developing psychiatric illness. Collectively, our current findings suggest that molecular changes may underlie alterations in cortical stress responsivity across the human lifespan. The functional characteristics of the novel and robustly expressed 67-kDa isoform, as well as the GRa-Dx variant, remain to be elucidated and may reveal added significance of the late adolescent and neonatal periods as windows of vulnerability in the development of the human cortical stress response.
